AU7525796A - Novel inhibitors of peptide binding to mhc class ii proteins - Google Patents

Novel inhibitors of peptide binding to mhc class ii proteins

Info

Publication number
AU7525796A
AU7525796A AU75257/96A AU7525796A AU7525796A AU 7525796 A AU7525796 A AU 7525796A AU 75257/96 A AU75257/96 A AU 75257/96A AU 7525796 A AU7525796 A AU 7525796A AU 7525796 A AU7525796 A AU 7525796A
Authority
AU
Australia
Prior art keywords
proteins
mhc class
peptide binding
novel inhibitors
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75257/96A
Inventor
Alan D. Adams
A. Brian Jones
Victoria K Lombardo
Richard L. Tolman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602976.4A external-priority patent/GB9602976D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU7525796A publication Critical patent/AU7525796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU75257/96A 1995-10-30 1996-10-25 Novel inhibitors of peptide binding to mhc class ii proteins Abandoned AU7525796A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US805995P 1995-10-30 1995-10-30
US008059 1995-10-30
GBGB9602976.4A GB9602976D0 (en) 1996-02-13 1996-02-13 Novel inhibitors of peptide binding to mhc class II proteins
GB9602976 1996-02-13
PCT/US1996/017333 WO1997016410A1 (en) 1995-10-30 1996-10-25 Novel inhibitors of peptide binding to mhc class ii proteins

Publications (1)

Publication Number Publication Date
AU7525796A true AU7525796A (en) 1997-05-22

Family

ID=26308693

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75257/96A Abandoned AU7525796A (en) 1995-10-30 1996-10-25 Novel inhibitors of peptide binding to mhc class ii proteins

Country Status (2)

Country Link
AU (1) AU7525796A (en)
WO (1) WO1997016410A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
ES2218796T3 (en) 1998-05-21 2004-11-16 Tecnogen Scpa USE OF A PEPTIDIC COMPOUND FOR THE TREATMENT OF SYSTEMIC ERIMATUS LUPUS.
US6569851B1 (en) 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
AU4707999A (en) * 1998-06-22 2000-01-10 Elan Pharmaceuticals, Inc. Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
US6958330B1 (en) 1998-06-22 2005-10-25 Elan Pharmaceuticals, Inc. Polycyclic α-amino-ε-caprolactams and related compounds
US6552013B1 (en) 1998-06-22 2003-04-22 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
JP2002518483A (en) * 1998-06-22 2002-06-25 エラン ファーマシューティカルズ，インコーポレイテッド Compounds for inhibiting β-amyloid peptide release and / or their synthesis
US11021514B2 (en) 2016-06-01 2021-06-01 Athira Pharma, Inc. Compounds

Also Published As

Publication number Publication date
WO1997016410A1 (en) 1997-05-09

Similar Documents

Publication Publication Date Title
AU6311996A (en) Peptide inhibitors of fibronectine
AU8118398A (en) Identification of mhc binding peptides
AU7678196A (en) Methods and compositions for the delivery of monomeric proteins
AU688210B2 (en) Recombinant obese (Ob) proteins
AU7604196A (en) Novel inhibitors of peptide binding to mhc class ii proteins
AU5132096A (en) Glubodies - multiplicities of proteins capable of binding a variety of small molecules
AU7473398A (en) Inhibitors of protein isoprenyl transferases
PL336889A1 (en) Preparations of activated protein c
AU5716696A (en) Decorin binding protein compositions and methods of use
AU4972096A (en) Peptides and compounds that bind to sh2 domains
AU2548097A (en) Formulations of ob protein
AU4413096A (en) Phenylalanine free proteins
AU2398997A (en) Modified ligands of calcium-dependent binding proteins
PL321161A1 (en) Novel mpnpclonal antibodies eacting as inhibitors in respect to phospholipase a2 og type ii and protein containing some of them
AU2091799A (en) Uses of alpha-conotoxin peptides
AU3804995A (en) Melanoma-associated protein
AU7525796A (en) Novel inhibitors of peptide binding to mhc class ii proteins
AU4977796A (en) Modified lysine or arginine containing proteins and peptides
AU6877998A (en) Dipeptide inhibitors of protein farnesyltransferase
AU4479096A (en) 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
EP0831878A4 (en) Novel peptide inhibitors of calmodulin
AU2186895A (en) Polypeptides of lipopolysaccharide binding protein
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof
IL116973A0 (en) Extraction of recombinant proteins
AU7475396A (en) Novel inhibitors of peptide binding to mhc class ii proteins